Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s footer revision number was updated from v3.5.2 to v3.5.3, indicating a maintenance/version update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:32:29.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new Revision: v3.5.2 was added and the previous Revision: v3.5.0 was removed from the page's revision history.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:13.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now includes Melanoma and related topics, such as MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-04-09T21:46:53.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Melanoma and the related topic MedlinePlus Genetics were removed from the page.
    Difference
    0.2%
    Check dated 2026-04-02T15:34:22.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added Melanoma label and related topics (MedlinePlus Genetics). Site revision updated to v3.5.0, replacing v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-19T05:17:05.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:47.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.